Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

475.517
+6.4061.37%
Number of Gainers:24
Number of Losers:25
Number of Flat:2
PE:- -
High:479.862
Open:468.227
Low:465.418
Close:469.111
Volume:368.12M
Turnover:10.79B
Market Cap:2.98T
Float Cap:2.09T

Loading ...

Morgan Stanley Trims China Resources Beer Target to HK$30, Keeps Overweight Stance

Stock News
·
Aug 21

Meituan's Food Delivery Platform Introduces New Location-Based Store Tags for Enhanced User Experience

Deep News
·
Aug 21

China Resources Beer's Baijiu Business Likely to Only Recover in Longer Term

Dow Jones
·
Aug 21

Luye Pharma's Vaccine for Cervical Precancerous Lesions to Enter Phase II Trial

MT Newswires Live
·
Aug 21

Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains

Stock News
·
Aug 21

Shareholder Offloads Nearly 7 Billion Yuan in Precision-Timed Selloff, Stake Drops to 3.79%

Deep News
·
Aug 21

Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth

Stock News
·
Aug 21

ZYLOXTB Surges Over 9% Intraday on Strong H1 Net Profit of 179 Million Yuan, Up 47.8% Year-On-Year

Deep News
·
Aug 21

Simcere Pharmaceutical Group's H1 Attributable Profit Rises 38%

MT Newswires Live
·
Aug 21

Press Release: Sunshine Guojian Releases 2026 Interim Report:

Dow Jones
·
Aug 21

Everest Medicines Limited (HKG:1952) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Simply Wall St.
·
Aug 21

Canada's Diamond Estates Q1 Revenue Falls on Lower Winery Shipments

Reuters
·
Aug 21

Keymed Biosciences (SEHK:2162) Stock Questions Whether New Profit Can Last

Simply Wall St.
·
Aug 21

Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%

THOMSON REUTERS
·
Aug 20

Simcere Pharma's Half-Year Profit Jumps 48.7% on Adjusted Basis

Stock News
·
Aug 20

Simcere Pharma Appoints Zhu Da as Joint Company Secretary

Stock News
·
Aug 20

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Reuters
·
Aug 20

Simcere Pharmaceutical Posts HY Net Income Attributable of RMB 829 MLN

Reuters
·
Aug 20

Simcere Pharmaceutical Files Board, Committee Member List with Disclosure Responsibilities

Reuters
·
Aug 20

Simcere Pharmaceutical Launches Open-Market Share Buyback of up to RMB 1 Billion

Reuters
·
Aug 20